FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY ASR SLEEVE

MDR report key: 3870940 · Received June 12, 2014

Report

Report Number
1818910-2014-20925
Event Type
Injury
Date Received
June 12, 2014
Date of Event
May 23, 2014
Report Date
July 11, 2014
Manufacturer
DEPUY INTERNATIONAL LTD.-8010379
Product Code
KXA
PMA / PMN Number
PUNKNOWN
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THIS INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

ASR REVISION REPORTED VIA SALES REP, ASR XL, RIGHT, REASON(S) FOR REVISION : PAIN / HIGH COCR LEVELS.

Description of Event or Problem · 1

UPDATE REC'D 7/11/2014 - MEDICAL RECORDS RECEIVED. UPON REVISION, TISSUE DISCOLORATION, GREY BURSAL TISSUE, METALLIC WEAR, AND A SMALL AMOUNT OF DISCOLORATION ON THE MORSE TAPER WITH NO CORROSION WERE NOTED. THE INFORMATION RECEIVED DOES NOT CHANGE THE MDR DECISION. THIS COMPLAINT WAS UPDATED ON: 07/16/2014.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
347488 UNKNOWN DEPUY ASR SLEEVE HIP FEMORAL STEM/SLEEVE KXA DEPUY INTERNATIONAL LTD.-8010379 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention